Dumas, P., Villacreces, A., Guitart, A. V., Ali, E. H., Massara, L., Mansier, O., Bidet, A., Martineau, D., Fernandez, S., Leguay, T., Pigneux, A., Vigon, I., Pasquet, J. and Desplat, V.
Dual inhibition of FLT3 and AXL by gilteritinib overcomes hematopoietic niche-driven resistance mechanisms in FLT3-ITD acute myeloid leukemia. Clinical Cancer Research. August 16 2021. doi: 10.1158/1078-0432.ccr-20-3114
Menu
